Literature DB >> 12624219

Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation.

Hakan Ay1, E Murat Arsava, S Lale Tokgözoglu, Necla Ozer, Okay Saribas.   

Abstract

BACKGROUND AND
PURPOSE: Blood stasis is the fundamental mechanism leading to thrombus formation in the venous system. Homocysteine also poses a significant risk for venous thrombosis through its endothelial toxic and prothrombotic properties. In the present study, we hypothesized that high homocysteine might be associated with thrombus formation in another stasis-related condition, atrial fibrillation.
METHODS: Forty-two consecutive patients with ischemic stroke caused by nonvalvular atrial fibrillation and admitted within the first day of symptom onset were included. Total fasting plasma homocysteine, serum folic acid, and vitamin B12 levels were measured. All patients were evaluated by transesophageal echocardiography for the presence of a left atrial (LA) thrombus. Homocysteine and vitamin levels were compared between groups with or without LA thrombus.
RESULTS: Transesophageal echocardiography revealed LA thrombus in 20 patients. Mean homocysteine levels were significantly higher in patients with LA thrombus (20.75 versus 13.34 micromol/L, P<0.001). Multivariate logistic regression analysis showed that the effect of high homocysteine was independent of other clinical or echocardiographic variables known to increase LA thrombus (P=0.017). There was no difference in vitamin B12 levels between groups (P=0.118), whereas the mean folic acid level was significantly lower in patients with LA thrombus (P=0.004).
CONCLUSIONS: High plasma homocysteine conveys an independent risk for LA thrombus formation in patients with stroke caused by nonvalvular atrial fibrillation. This finding further supports the thrombogenic role of high homocysteine in conditions associated with blood stasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624219     DOI: 10.1161/01.STR.0000060202.63475.BA

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Thrombophilia in ischemic stroke subtypes: implications for treatment.

Authors:  Cathy M Helgason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  Extremely atypical thrombus coating the left atrium and left atrial appendage.

Authors:  Andreia Fernandes; Joana Trigo; Gisela Costa; Joao Pais
Journal:  BMJ Case Rep       Date:  2014-02-03

3.  Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections.

Authors:  Carsten Konrad; Georg A Müller; Claus Langer; Gregor Kuhlenbäumer; Klaus Berger; Darius G Nabavi; Rainer Dziewas; Florian Stögbauer; Erich B Ringelstein; Ralf Junker
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

4.  Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.

Authors:  Renate B Schnabel; Martin G Larson; Jennifer F Yamamoto; Lisa M Sullivan; Michael J Pencina; James B Meigs; Geoffrey H Tofler; Jacob Selhub; Paul F Jacques; Philip A Wolf; Jared W Magnani; Patrick T Ellinor; Thomas J Wang; Daniel Levy; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

5.  Plasma Total Homocysteine Level Is Related to Unfavorable Outcomes in Ischemic Stroke With Atrial Fibrillation.

Authors:  Ki-Woong Nam; Chi Kyung Kim; Sungwook Yu; Kyungmi Oh; Jong-Won Chung; Oh Young Bang; Gyeong-Moon Kim; Jin-Man Jung; Tae-Jin Song; Yong-Jae Kim; Bum Joon Kim; Sung Hyuk Heo; Kwang-Yeol Park; Jeong-Min Kim; Jong-Ho Park; Jay Chol Choi; Man-Seok Park; Joon-Tae Kim; Kang-Ho Choi; Yang Ha Hwang; Woo-Keun Seo
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

6.  Association of homocysteine and smoking with cerebral microemboli in patients with mechanical heart valves: a transcranial Doppler study.

Authors:  Alicia Mattia; M Reza Azarpazhooh; Claudio Munoz; Chrysi Bogiatzi; Mackenzie A Quantz; J David Spence
Journal:  Stroke Vasc Neurol       Date:  2017-11-16

Review 7.  Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation.

Authors:  Mario Piergiulio Pezzo; Antonella Tufano; Massimo Franchini
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

Review 8.  A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.

Authors:  Luxiang Shang; Ling Zhang; Yankai Guo; Huaxin Sun; Xiaoxue Zhang; Yakun Bo; Xianhui Zhou; Baopeng Tang
Journal:  Front Cardiovasc Med       Date:  2021-07-01

9.  Effect of advanced age on plasma homocysteine levels and its association with ischemic stroke in non-valvular atrial fibrillation.

Authors:  Yan Yao; Li-Jian Gao; Yong Zhou; Jing-Hua Zhao; Qiang Lv; Jian-Zeng Dong; Mei-Sheng Shang
Journal:  J Geriatr Cardiol       Date:  2017-12       Impact factor: 3.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.